Skip to main content

Advertisement

ADVERTISEMENT

News

NovoSorb BTM - PolyNovo 

https://clinicaltrials.gov/study/NCT06255990?term=skin%20substitute&rank=6

A 42-patient CT will investigate a novel dermal substitute, NovoSorb BTM, for the treatment of full-thickness skin defects versus SoC with primary outcome of skin elasticity at 1 year post-transplantation vs normal skin. Recruitment is ongoing with estimated study completion in June 2027. clinicaltrials.gov

Advertisement

Advertisement

Advertisement